We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

17 hedge funds and large institutions have $7.21M invested in Tempest Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

104% more capital invested

Capital invested by funds: $3.54M → $7.21M (+$3.68M)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

31% more funds holding

Funds holding: 13 → 17 (+4)

0.02% more ownership

Funds ownership: 2.24% → 2.27% (+0.02%)

Holders
17
Holders Change
+4
Holders Change %
+30.77%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$28.3K
2
Northern Trust
Northern Trust
Illinois
+$22.9K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$18.7K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$15.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$3.46K

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$13.1K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$746
3
Morgan Stanley
Morgan Stanley
New York
-$110
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$2.39M – – –
RSCM
2
Rock Springs Capital Management
Maryland
$1.91M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.5M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$580K +$15.2K +691 +4%
Fidelity International
5
Fidelity International
Bermuda
$301K – – –
BlackRock
6
BlackRock
New York
$193K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$155K -$746 -34 -0.7%
Renaissance Technologies
8
Renaissance Technologies
New York
$61K +$1.84K +84 +4%
Millennium Management
9
Millennium Management
New York
$39K +$28.3K +1,292 New
Northern Trust
10
Northern Trust
Illinois
$31.4K +$22.9K +1,043 New
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$25.7K +$18.7K +853 New
TRCT
12
Tower Research Capital (TRC)
New York
$20K +$3.46K +158 +31%
Morgan Stanley
13
Morgan Stanley
New York
$1.15K -$110 -5 -12%
JP Morgan Chase
14
JP Morgan Chase
New York
$1K +$526 +24 New
Osaic Holdings
15
Osaic Holdings
Arizona
$232 +$175 +8 New
Wells Fargo
16
Wells Fargo
California
$158 – – –
Bank of America
17
Bank of America
North Carolina
$21 – – –
Franklin Resources
18
Franklin Resources
California
– -$13.1K -870 Closed

TPST Hedge Fund Activity: Q1 2023 in Review

17 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2023, worth a combined $7.21M — up 104% from $3.54M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TPST positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $28.3K. The largest seller was Franklin Resources, exiting entirely with an estimated $13.1K sold.

  • 17 institutional investors held Tempest Therapeutics (TPST) as of Q1 2023, up from 13 in Q4 2022.
  • Funds reported $7.21M of Tempest Therapeutics stock for Q1 2023, up 104% quarter-over-quarter.
  • 5 funds opened new Tempest Therapeutics positions in Q1 2023 and 1 closed out, a net change of +4 holders.
  • The largest Tempest Therapeutics buyer in Q1 2023 was Millennium Management, an estimated $28.3K added.
  • The largest Tempest Therapeutics seller in Q1 2023 was Franklin Resources, an estimated $13.1K sold.

Based on aggregated 13F filings for Q1 2023.